Automata Featured in NVIDIA’s GTC Berlin Announcement on Advancing AI-Driven Biology

On October 21, 2026, at GTC Berlin, NVIDIA announced work with healthcare and life sciences organizations to advance AI-driven biology and drug discovery. Automata is among the organizations featured for its work using NVIDIA’s technologies to connect scientific agents with automated lab infrastructure.

LINQ combines adaptable workcells and orchestration software to bring instruments and workflows into one coordinated environment. It gives labs a way to run automate more of their scientific process today, while establishing a foundation for more intelligent operations as their needs evolve.

The work in NVIDIA’s announcement explores using NVIDIA Nemotron to develop scientific agents that connect autonomous laboratories and biological discovery, helping researchers move from hypothesis to experiments faster.

Read NVIDIA’s full announcement here.

Learn more about the lab automation infrastructure behind this work by exploring Automata’s LINQ platform.

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the world leader in AI and accelerated computing.